Tim Hart, CEO of Zyoxel, talks about the problem of high failure rate of drug companies to create new drugs. Professor Zhanfeng Cui talks about developments Zyoxel are making in three dimensional cell culture studies that can reduce these failure rates
Tim Hart and Zhanfeng Cui on Isis Innovation
Series:
People:
Oxford Unit:
More in this Series...
Isis Innovation is the University of Oxford's technology company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Isis files on average one new patent application each week, has concluded over 400 technology licensing agreements, and established 62 new spin-out companies from Oxford. Isis also manages Oxford University...